Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 40

Results For "Innovation"

1381 News Found

Fischer Medical Venture and BluSim Tech partner to redefine elderly care
Healthcare | June 10, 2024

Fischer Medical Venture and BluSim Tech partner to redefine elderly care

his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio


Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing
News | June 09, 2024

Ecolab and Repligen launch DurA Cycle affinity resin for biologic manufacturing

DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,


Borosil Scientific debuts on stock exchange
News | June 08, 2024

Borosil Scientific debuts on stock exchange

This strategic decision will unlock significant value for our scientific and industrial products business


Orchid Pharma receives DCGI approval for combination of Cefepime and Enmetazobactam
Drug Approval | June 07, 2024

Orchid Pharma receives DCGI approval for combination of Cefepime and Enmetazobactam

DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable


Merck's oncology pipeline of DDRi and ADC poised to advance cancer treatment
Diagnostic Center | June 04, 2024

Merck's oncology pipeline of DDRi and ADC poised to advance cancer treatment

Merck shared updates on the company’s oncology pipeline and focused R&D approach


PharmaLytica 2024: India exported US$ 27.8 billion worth of drugs in FY 2023-24
News | June 03, 2024

PharmaLytica 2024: India exported US$ 27.8 billion worth of drugs in FY 2023-24

The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030


Supriya Lifescience FY24 PAT up 32%
News | June 03, 2024

Supriya Lifescience FY24 PAT up 32%

The Profit After Tax (PAT) for Q4 FY24 at Rs 36.40 crore, compared to Rs 38.23 crore in Q4 FY23


BlueRock Therapeutics receives FDA RMAT designation for Parkinson’s disease cell therapy candidate bemdaneprocel
Drug Approval | May 31, 2024

BlueRock Therapeutics receives FDA RMAT designation for Parkinson’s disease cell therapy candidate bemdaneprocel

Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease


Merck inks MoU with KAIST to advance scientific collaboration
News | May 30, 2024

Merck inks MoU with KAIST to advance scientific collaboration

Partnership to facilitate collaborative research in academia and industry to further progress in life sciences


Valent BioSciences opens new addition at Melnik and Shafer Biorational Research Center
News | May 30, 2024

Valent BioSciences opens new addition at Melnik and Shafer Biorational Research Center

Greg was also central to the planning, design, and construction of this facility